3 studies found for:    15329413 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer
Condition: Non-small-cell Lung Cancer
Interventions: Drug: Nimotuzumab;   Drug: docetaxel and cisplatin;   Radiation: daily RT (65Gy in 25 fractions) to the chest;   Drug: placebo
2 Withdrawn A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Drug: BIBW 2992 (Afatinib)
3 Unknown  Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Procedure: FDG-/FLT-PET

Indicates status has not been verified in more than two years